SCHEMBL6016741

SCHEMBL6016741

CCOC(=O)CC(C)c1ccc(Nc2nc(Nc3ccc4c(c3)OCCO4)ncc2F)cc1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SYK P43405 16/20 0.62
EGFR P00533 3/20 0.55
STK17A Q9UEE5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656379 0.84 SYK (0.70) SYK
SCHEMBL656845 0.84 SYK (0.70) SYK
SCHEMBL657950 0.83 SYK (0.68) SYKEGFR
SCHEMBL654418 0.83 SYK (0.68) SYKEGFR
SCHEMBL655775 0.82 SYK (0.78) SYKEGFR
SCHEMBL655167 0.82 SYK (0.78) SYKEGFR
SCHEMBL656158 0.82 SYK (0.69) SYKEGFRSTK17A
SCHEMBL655873 0.81 SYK (0.61) SYKEGFRSTK17A
SCHEMBL27632112 0.81 SYK (0.59) SYKEGFRSTK17A
SCHEMBL655299 0.80 SYK (0.67) SYKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471915-A4 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS INC (US) 2006-02-15 EP disclosed
EP-1471915-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Rigel Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
WO-2003063794-A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES RIGEL PHARMACEUTICALS, INC. (US) 2003-08-07 WO disclosed